Cross-Titrating from Duloxetine to Venlafaxine
Rationale for Cross-Titration Strategy
- Venlafaxine has a shorter half-life and is particularly prone to withdrawal symptoms, requiring gradual tapering when discontinued, as recommended by the Mayo Clinic 1, 2, 3
Recommended Cross-Titration Protocol
- Start venlafaxine XR at 37.5 mg once or twice daily while maintaining current duloxetine dose, as suggested by the Mayo Clinic Proceedings and the Journal of the National Comprehensive Cancer Network 3, 4
- Monitor for nausea, which is common with both medications, according to the Mayo Clinic Proceedings 1, 5
- Increase venlafaxine by 75 mg weekly as tolerated, targeting 150-225 mg/day for therapeutic effect, as recommended by the Mayo Clinic Proceedings and the Journal of the National Comprehensive Cancer Network 3, 4
Critical Monitoring Points
- Monitor blood pressure closely during venlafaxine titration, as increases can occur and cardiac conduction abnormalities have been reported, according to the Mayo Clinic Proceedings 1, 5, 3
- Venlafaxine should be prescribed with caution in patients with cardiac disease, as recommended by the Mayo Clinic Proceedings 1, 3